Drug Prices

NPPA under fire for 50% rise in drug prices, panel demands explanation

Parliamentary panel slams drug pricing regulator for hike on 11 drugs used for treating conditions such as asthma, glaucoma, thalassemia, tuberculosis, and mental health disorders

NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

The ceiling prices of seven other drugs were revised to include the impact of the 0.00551 per cent increase in drug prices in the National List of Essential Medicines

Imports of bulk drugs grew by 13.06% in April-May as prices cooled

Industry insiders say pharma players are taking advantage and stocking up on APIs

Indian pharmaceutical companies likely to cash in on US drug shortages

US drug shortages hit a decade-high of 323 across 22 therapies in the March quarter of 2024

Panel formed to administer pricing reforms for drugs, medical devices

Centre constitutes Committee for reforms in pricing framework for drugs and medical devices

Cipla, Ipca Lab, Zydus Life to benefit most from drug price rise: Analysts

The recent price hike, analysts said, brings some respite for the industry facing multiple headwinds such as steep raw inflation, price erosion in the US market and higher freight costs.

Power crisis brewing in China likely to hit Indian pharma companies

Delays in consignments, rising prices of key ingredients worry industry

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

Donald Trump signs new, expanded executive order to lower US drug prices

Donald Trump signed a new executive order on Sunday aimed at lowering drug prices in the United States by linking them to those of other nations and expanding the scope of a July action

Drug price monitoring unit set up in Karnataka under aegis of NPPA

The government on Thursday said aprice monitoring and resource unit (PMRU) has been set up in Karnataka under the aegis of the National Pharmaceutical Pricing Authority (NPPA)

More drugs may see price revisions as raw material costs, expenses rise

API prices have gone up by 25-30 per cent for some drugs in recent months

Remdesivir pricing in India likely to be lower than global rate: Sources

Indian companies await clarity from the drug regulator on animal toxicology study before they can launch here

A lesson to learn: Economic problems can have counter-intuitive solutions

From drug price ceiling to additional duties on steel imports and export ban to counter onion shortage - govt response to several problems shows the lessons may not have been learnt, writes T N Ninan

Novartis, Merck, Allergan raise US prices, 445 drugs to cost more in 2020

That is above the average of 404 drug price increases in the first three days of January over the past five years

Govt reviews industry's demands to implement changes in drug price policy

A senior government official said the industry has been requesting for an amendment to allow them to implement the price change from the next batch.

Best of BS Opinion: Green shoots in financial sector, price hike, and more

Kanika Datta sums up the best of BS Opinion articles: from why the public should be consulted in redesigning New Delhi and why the government must not control drug prices.

Price hike, at last

Govt should not control drug prices

HC rulings on arbitration to drug prices, here're the key court orders

The Supreme Court has ruled that a hospital trust buying flats to accommodate its nurses could be called a 'consumer' under the Consumer Protection Act

Govt considering one-time settlement option in drug overcharging cases

Pharma companies feel that working out an overarching solution for the entire industry is cumbersome and unlikely to work out

Bills for pills: Antibiotics could be govt's next segment for price cap

Centre likely to consider rationalising trade margins